Annual Total Liabilities
$6.86 M
-$8.70 M-55.93%
31 December 2023
Summary:
Trevi Therapeutics annual total liabilities is currently $6.86 million, with the most recent change of -$8.70 million (-55.93%) on 31 December 2023. During the last 3 years, it has fallen by -$12.99 million (-65.46%). TRVI annual total liabilities is now -67.96% below its all-time high of $21.40 million, reached on 31 December 2021.TRVI Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$9.94 M
+$2.30 M+30.16%
30 September 2024
Summary:
Trevi Therapeutics quarterly total liabilities is currently $9.94 million, with the most recent change of +$2.30 million (+30.16%) on 30 September 2024. Over the past year, it has increased by +$3.65 million (+58.11%). TRVI quarterly total liabilities is now -53.58% below its all-time high of $21.41 million, reached on 30 June 2021.TRVI Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRVI Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -55.9% | +58.1% |
3 y3 years | -65.5% | -50.8% |
5 y5 years | +60.3% | +87.1% |
TRVI Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -68.0% | at low | -53.6% | +68.3% |
5 y | 5 years | -68.0% | +60.3% | -53.6% | +87.1% |
alltime | all time | -68.0% | +60.3% | -53.6% | +132.3% |
Trevi Therapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $9.94 M(+30.2%) |
June 2024 | - | $7.64 M(+22.7%) |
Mar 2024 | - | $6.22 M(-9.2%) |
Dec 2023 | $6.86 M(-55.9%) | $6.86 M(+9.1%) |
Sept 2023 | - | $6.29 M(+6.5%) |
June 2023 | - | $5.90 M(-59.2%) |
Mar 2023 | - | $14.47 M(-7.0%) |
Dec 2022 | $15.56 M(-27.3%) | $15.56 M(-15.7%) |
Sept 2022 | - | $18.46 M(-11.7%) |
June 2022 | - | $20.90 M(+4.9%) |
Mar 2022 | - | $19.92 M(-6.9%) |
Dec 2021 | $21.40 M | $21.40 M(+5.9%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $20.22 M(-5.6%) |
June 2021 | - | $21.41 M(+11.6%) |
Mar 2021 | - | $19.18 M(-3.4%) |
Dec 2020 | $19.85 M(+263.8%) | $19.85 M(-2.0%) |
Sept 2020 | - | $20.26 M(+190.6%) |
June 2020 | - | $6.97 M(-6.2%) |
Mar 2020 | - | $7.44 M(+36.3%) |
Dec 2019 | $5.46 M(+27.5%) | $5.46 M(+2.7%) |
Sept 2019 | - | $5.31 M(-28.3%) |
June 2019 | - | $7.41 M(+64.4%) |
Mar 2019 | - | $4.51 M(+5.4%) |
Dec 2018 | $4.28 M(-42.6%) | $4.28 M |
Dec 2017 | $7.45 M | - |
FAQ
- What is Trevi Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Trevi Therapeutics?
- What is Trevi Therapeutics annual total liabilities year-on-year change?
- What is Trevi Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly total liabilities year-on-year change?
What is Trevi Therapeutics annual total liabilities?
The current annual total liabilities of TRVI is $6.86 M
What is the all time high annual total liabilities for Trevi Therapeutics?
Trevi Therapeutics all-time high annual total liabilities is $21.40 M
What is Trevi Therapeutics annual total liabilities year-on-year change?
Over the past year, TRVI annual total liabilities has changed by -$8.70 M (-55.93%)
What is Trevi Therapeutics quarterly total liabilities?
The current quarterly total liabilities of TRVI is $9.94 M
What is the all time high quarterly total liabilities for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly total liabilities is $21.41 M
What is Trevi Therapeutics quarterly total liabilities year-on-year change?
Over the past year, TRVI quarterly total liabilities has changed by +$3.65 M (+58.11%)